Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Haitao Zhao, Junyu Long et al.|Hepatology International|2023Cited by 60
Decoding the SHOX2 methylation-expression paradox in lung adenocarcinoma: Dual-regulatory methylation patterns drive oncogenic activation and prognostic relevanceYang Zhou, Jie He, Ruochuan Zang et al.|Cancer Letters|2026Cited by 0